UC BON.CAP.CERT. 09/24 OMV/ DE000HC9KTA8 /
07/06/2024 21:45:15 | Chg.+0.010 | Bid21:59:01 | Ask21:59:01 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
47.530EUR | +0.02% | 47.450 Bid Size: 400 |
47.880 Ask Size: 400 |
OMV AG | - EUR | 27/09/2024 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
13/10/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
28/07/2021
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center